Belching: Pathogenesis, Clinical Characteristics, and Treatment Strategies.
Journal
Journal of clinical gastroenterology
ISSN: 1539-2031
Titre abrégé: J Clin Gastroenterol
Pays: United States
ID NLM: 7910017
Informations de publication
Date de publication:
01 01 2022
01 01 2022
Historique:
pubmed:
6
11
2021
medline:
3
2
2022
entrez:
5
11
2021
Statut:
ppublish
Résumé
Belching is a common condition that frequently overlaps with other functional gastrointestinal disorders. While not associated with any increase in mortality, it is associated with impaired health-related quality of life. Management is challenging, as there are no pharmacologic therapies specifically targeted towards this disorder. This review covers pathogenesis, prevalence, and treatments for this condition, with specific emphasis on the evolving role of behavioral treatments in management. The diagnosis of gastric and supragastric belching can usually be made clinically, without the need for invasive testing. If necessary, multichannel intraluminal impedance and pH testing can provide a more definitive diagnosis and can also be used to estimate the frequency of gastric and supragastric belching episodes, which each have a distinct appearance on impedance tracing. Belching disorders are commonly associated with gastroesophageal reflux disease and functional disorders of the gastrointestinal tract. Supragastric belching is also associated with behavioral disorders like anxiety and obsessive-compulsive disorder. Speech therapy, cognitive-behavioral therapy, and diaphragmatic breathing are all interventions that have recently shown promise in the management of this challenging disorder.
Identifiants
pubmed: 34739403
doi: 10.1097/MCG.0000000000001631
pii: 00004836-202201000-00017
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
36-40Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Stanghellini V, Chan FKL, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–1392.
Bredenoord AJ, Weusten BLAM, Sifrim D, et al. Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut. 2004;53:1561–1565.
Zad M, Bredenoord AJ. Chronic burping and belching. Curr Treat Options Gastroenterol. 2020;18:33–42.
Bredenoord AJ, Weusten BLAM, Timmer R, et al. Psychological factors affect the frequency of belching in patients with aerophagia. Am J Gastroenterol. 2006;101:2777–2781.
Kessing BF, Bredenoord AJ, Smout AJPM. The pathophysiology, diagnosis and treatment of excessive belching symptoms. Am J Gastroenterol. 2014;109:1196–1203.
Kessing BF, Bredenoord AJ, Smout AJPM. Mechanisms of gastric and supragastric belching: a study using concurrent high-resolution manometry and impedance monitoring. Neurogastroenterol Motil. 2012;24:e573–e579.
Bredenoord AJ, Smout AJPM. Physiologic and pathologic belching. Clin Gastroenterol Hepatol. 2007;5:772–775.
Bredenoord AJ. Excessive belching and aerophagia: two different disorders. Dis Esophagus. 2010;23:347–352.
Dent J, Holloway RH, Toouli J, et al. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut. 1988;29:1020–1028.
Bredenoord AJ, Weusten BLAM, Timmer R, et al. Relationships between air swallowing, intragastric air, belching and gastro-oesophageal reflux. Neurogastroenterol Motil. 2005;17:341–347.
Karamanolis G, Triantafyllou K, Tsiamoulos Z, et al. Effect of sleep on excessive belching: a 24-hour impedance-pH study. J Clin Gastroenterol. 2010;44:332–334.
Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders: results of Rome Foundation Global Study. Gastroenterology. 2021;160:99.e3–114.e3.
Koukias N, Woodland P, Yazaki E, et al. Supragastric belching: prevalence and association with gastroesophageal reflux disease and esophageal hypomotility. J Neurogastroenterol Motil. 2015;21:398–403.
Park JM, Choi M-G, Cho YK, et al. Functional gastrointestinal disorders diagnosed by Rome III Questionnaire in Korea. J Neurogastroenterol Motil. 2011;17:279–286.
Piessevaux H, De Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil. 2009;21:378–388.
Lin M, Triadafilopoulos G. Belching: dyspepsia or gastroesophageal reflux disease? Am J Gastroenterol. 2003;98:2139–2145.
Conchillo JM, Selimah M, Bredenoord AJ, et al. Air swallowing, belching, acid and non-acid reflux in patients with functional dyspepsia. Aliment Pharmacol Ther. 2007;25:965–971.
Yao X, Yang YS, Cui LH, et al. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: a multicenter study. J Gastroenterol Hepatol. 2016;31:1584–1593.
Broeders JAJL, Bredenoord AJ, Hazebroek EJ, et al. Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut. 2011;60:435–441.
Kessing BF, Broeders JAJL, Vinke N, et al. Gas-related symptoms after antireflux surgery. Surg Endosc. 2013;27:3739–3747.
Bredenoord AJ, Smout AJ. Impaired health-related quality of life in patients with excessive supragastric belching. Eur J Gastroenterol Hepatol. 2010;22:1420–1423.
Bredenoord AJ. Management of belching, hiccups, and aerophagia. Clin Gastroenterol Hepatol. 2013;11:6–12.
Ouyang A, Locke GR. Overview of neurogastroenterology-gastrointestinal motility and functional GI disorders: classification, prevalence, and epidemiology. Gastroenterol Clin North Am. 2007;36:485–498; vii.
Hemmink GJM, Weusten BLAM, Bredenoord AJ, et al. Increased swallowing frequency in GORD is likely to be caused by perception of reflux episodes. Neurogastroenterol Motil. 2009;21:143–148.
Bredenoord AJ, Weusten BLAM, Timmer R, et al. Air swallowing, belching, and reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2006;101:1721–1726.
Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–208.
Sifrim D, Silny J, Holloway RH, et al. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut. 1999;44:47–54.
Hemmink GJM, Bredenoord AJ, Weusten BLAM, et al. Supragastric belching in patients with reflux symptoms. Am J Gastroenterol. 2009;104:1992–1997.
Kessing BF, Bredenoord AJ, Velosa M, et al. Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2012;35:1073–1079.
Sawada A, Guzman M, Nikaki K, et al. Identification of different phenotypes of esophageal reflux hypersensitivity and implications for treatment. Clin Gastroenterol Hepatol. 2021;19:690.e2–698.e2.
Kessing BF, Bredenoord AJ, Smout AJPM. Objective manometric criteria for the rumination syndrome. Am J Gastroenterol. 2014;109:52–59.
Rommel N, Tack J, Arts J, et al. Rumination or belching-regurgitation? Differential diagnosis using oesophageal impedance-manometry. Neurogastroenterol Motil. 2010;22:e97–e104.
Ten Cate L, Herregods TVK, Dejonckere PH, et al. Speech therapy as treatment for supragastric belching. Dysphagia. 2018;33:707–715.
Hemmink GJM, Ten Cate L, Bredenoord AJ, et al. Speech therapy in patients with excessive supragastric belching—a pilot study. Neurogastroenterol Motil. 2010;22:24–28; e2–e3.
Glasinovic E, Wynter E, Arguero J, et al. Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux. Am J Gastroenterol. 2018;113:539–547.
Riehl ME, Kinsinger S, Kahrilas PJ, et al. Role of a health psychologist in the management of functional esophageal complaints. Dis Esophagus. 2015;28:428–436.
Sawada A, Anastasi N, Green A, et al. Management of supragastric belching with cognitive behavioural therapy: factors determining success and follow-up outcomes at 6-12 months post-therapy. Aliment Pharmacol Ther. 2019;50:530–537.
Ong AM-L, Chua LT-T, Khor CJ-L, et al. Diaphragmatic breathing reduces belching and proton pump inhibitor refractory gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol. 2018;16:407.e2–416.e2.
Katzka DA. Simple office-based behavioral approach to patients with chronic belching. Dis Esophagus. 2013;26:570–573.
Cigrang JA, Hunter CM, Peterson AL. Behavioral treatment of chronic belching due to aerophagia in a normal adult. Behav Modif. 2006;30:341–351.
Blondeau K, Boecxstaens V, Rommel N, et al. Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching. Clin Gastroenterol Hepatol. 2012;10:379–384.